• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The PB2 subunit of the influenza virus RNA polymerase

Anne

Senior Moderator
The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with MAVS and inhibiting IFN-{beta} expression.

http://www.ncbi.nlm.nih.gov/pubmed/20538852


Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, Subbarao K, Fodor E.
Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20892, USA; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK; and Medical Countermeasures (Biological) Laboratory, DMERI, DSO National Laboratories, Singapore 117510.
Abstract

The PB2 subunit of the influenza virus RNA polymerase is a major virulence determinant of influenza viruses. However the molecular mechanisms involved remain unknown. It was previously shown that the PB2 protein, in addition to its nuclear localization, also accumulates in the mitochondria. Here, we demonstrate that the PB2 protein interacts with the mitochondrial antiviral signaling protein, MAVS (also known as IPS-1, VISA, or Cardif), and inhibits MAVS-mediated IFN-beta expression.

In addition, we show that PB2 proteins of influenza viruses differ in their abilities to associate with the mitochondria. In particular, the PB2 proteins of seasonal human influenza viruses localize to the mitochondria while PB2 proteins of avian influenza viruses are non-mitochondrial. This difference in localization is caused by a single amino acid polymorphism in the PB2 mitochondrial targeting signal. In order to address the functional significance of the mitochondrial localization of the PB2 protein in vivo, we have generated two recombinant human influenza viruses encoding either mitochondrial or non-mitochondrial PB2 proteins. We found that the difference in the mitochondrial localization of the PB2 proteins does not affect the growth of these viruses in cell culture. However, the virus encoding the non-mitochondrial PB2 protein induces higher levels of IFN-beta and, in an animal model, is attenuated compared to the isogenic virus encoding a mitochondrial PB2. Overall this study implicates the PB2 protein in the regulation of host antiviral innate immune pathways and suggests an important role for the mitochondrial association of the PB2 protein in determining virulence.

PMID: 20538852 [PubMed - as supplied by publisher]
 
Re: The PB2 subunit of the influenza virus RNA polymerase

no hit on mitochondr* in that .pdf
 
Re: The PB2 subunit of the influenza virus RNA polymerase

http://www.ncbi.nlm.nih.gov/pubmed/16242167

> We show that an N-terminal motif composed of 120 amino acids is sufficient for localization
> of PB2 to mitochondria.
> In particular, leucine residues at positions 7 and 10 were essential for mitochondrial
> targeting. Recombinant influenza A/WSN/33 viruses expressing PB2 proteins with
> L7A and/or L10A mutations showed reduced viral titers, but unaffected levels of transcription,
> replication, and protein expression. The introduction of L7A and/or L10A mutations into
> recombinant viruses correlated with reduced mitochondrial membrane potential in infected cells,
> suggesting that mitochondrial localization of PB2 contributes to the preservation of
> mitochondrial function during influenza virus infection

but almost all PB2 have 7L and 10L , avian or human
N-terminal : http://en.wikipedia.org/wiki/N-terminus


------------------------------------------

http://www.ncbi.nlm.nih.gov/pubmed/20181719
PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in
mammalian host cells.

> in addition to the E627K mutation, the PB2 mutation T271A enhances polymerase activity
> in human cells
>... PB2 of the 2009 pandemic H1N1 influenza virus has 271A.


avian_position_human markers
PB2:A44S,M64T,A199S,T271A,L475M,D567N,A588I,E627K,A674T,K702R

keyword Finkelstein, diary 1600
PB2:Q151H,R324S,Y432H

brevig hatte T108A(1),A199S(1),T552S(3)

T108A(1),V114I(1),A199S(1),L475M(1),I539V(1),D567N(1),E627K(1),K702R(1)

Chen,Shih:
A684S(1),T271A(1)

amino-acid differences brevig vs. i_bird:
T108A(1),V114I(1),A199S(1),L475M(1),I539V(1),D567N(1),E627K(1),K702R(1),

i_bird has 271T , early swine,human have 271T until ~1940

-------------------------------------------
 
Back
Top